Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming
about
Muse cells and induced pluripotent stem cell: implication of the elite modelYoung at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellsReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementTwo Effective Routes for Removing Lineage Restriction Roadblocks: From Somatic Cells to HepatocytesInduction of pluripotency by defined factorsRecombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyondInvestigating cellular identity and manipulating cell fate using induced pluripotent stem cellsTechniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell DerivationStepping back to move forward: a current review of iPSCs in the fight against Alzheimer's diseaseUtilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neuronsConcise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem CellsPresent and future challenges of induced pluripotent stem cellsOvercoming the hurdles for a reproducible generation of human functionally mature reprogrammed neuronsChoices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming StrategiesGPAT2, a mitochondrial outer membrane protein, in piRNA biogenesis in germline stem cellsConcise review: alchemy of biology: generating desired cell types from abundant and accessible cells.The elite and stochastic model for iPS cell generation: multilineage-differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells.Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.Transgene excision has no impact on in vivo integration of human iPS derived neural precursorsTurning straw into gold: directing cell fate for regenerative medicine.Induced pluripotent stem cells--opportunities for disease modelling and drug discovery.Methods for iPS cell generation for basic research and clinical applications.Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogrammingPrediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes.Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells.Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factorsRecessive cardiac phenotypes in induced pluripotent stem cell models of Jervell and Lange-Nielsen syndrome: disease mechanisms and pharmacological rescue.Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells.Efficient Gene Editing in Pluripotent Stem Cells by Bacterial Injection of Transcription Activator-Like Effector Nuclease ProteinsGenetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential.Distinctive features of single nucleotide alterations in induced pluripotent stem cells with different types of DNA repair deficiency disorders.Novel Strategy to Control Transgene Expression Mediated by a Sendai Virus-Based Vector Using a Nonstructural C Protein and Endogenous MicroRNAs.Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics.An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils.Vascular Smooth Muscle Cells From Hypertensive Patient-Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics.Generation of a High Number of Healthy Erythroid Cells from Gene-Edited Pyruvate Kinase Deficiency Patient-Specific Induced Pluripotent Stem Cells.Application of Induced Pluripotent Stem Cells in Liver DiseasesGeneration of cleidocranial dysplasia-specific human induced pluripotent stem cells in completely serum-, feeder-, and integration-free culture.Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells.
P2860
Q24625690-33123339-FAA4-478A-84EE-4EDE74989727Q26750663-A3853FBE-3812-4EA5-B14F-CB779D5BB23CQ26769878-AE5983E1-A273-4DAA-8266-5B1BD978C8BEQ26784188-61B6B60F-ECDA-4AB0-B4F0-A6171973DD1DQ26830425-7EC3898F-61CB-4843-9544-872E1A48D08DQ26861563-C5DB2A5E-1C4A-4272-BAF2-31DA144FF90EQ27025379-E4900CF4-6CC0-47C8-88D4-8CF881F25E9CQ28066087-453E0431-4BA2-4418-BEF3-2F747C4DA0ACQ28073143-073AA3CF-AC1A-4FFA-BD86-E67F060380A9Q28081565-24D3C7D5-A260-4216-92DD-D93AB72BDB25Q28081651-3AE0039E-6203-4C3A-9011-0B2DAC0CDBA6Q28082747-87E3F906-5C4C-44A3-8416-053F3DEE8D22Q28083762-66FA401C-37D7-4F66-B9CB-565D6DBBEB68Q28085565-3FAB6361-7F65-47A4-9D16-B5B40900566FQ28854373-A5B631DA-506F-4DC2-8691-186366EF1F30Q34028987-F7E2C667-8445-4E72-9D3C-6331EC429C86Q34032363-1509529C-E596-49DA-98F5-76FAF316C44FQ34033280-FB0AE369-ABA0-4A15-BA30-4551B1B637A4Q34035837-79047DBA-4096-4CB3-9E31-989F93A15DE6Q34169386-2530C871-FB3B-49F5-864B-29C5B4387557Q34231818-10E632E7-F29E-4914-8599-595169F5F285Q34257813-CCD1E83C-2B08-4D53-A327-B6BC2AC183E1Q34530121-309D8770-92ED-4487-B0D6-1111875C5930Q34601581-ED7DDCB7-793E-4A4D-BF57-B3E47793C140Q34601924-C2C97771-A5A9-4BB8-B23A-EC4E36125FF8Q34661781-E0B16137-A5D0-48A4-B58A-6C8B055E9802Q34738075-6CBCD908-FB86-4A88-A93F-EA7E6D453463Q34752070-0A9288AD-C111-46FC-A32F-E35EE0AFF4D0Q35653333-CD10AEFF-BDAE-40A7-A805-BD6CA98EEC6CQ35878885-076CFB1A-C597-4DD3-A6A8-49537D163CD2Q35896332-CC719E43-2216-42B6-B7EE-15C0D716EBADQ36023026-BD2E6F02-89C9-4FD5-BC6D-FE36B560A995Q36169226-5DAF0F4A-5D5F-4229-8A19-3B02C41A6CE8Q36335777-D46D50D0-81B9-41A9-8BB8-10E05A332003Q36358611-656BC1A4-583B-4EAF-8575-FF363D0A1DB5Q36362642-29BFFE32-1D23-4018-9295-BB5B4C828F42Q36379316-631EB4F1-D1FB-424E-92B5-2ED3EC098D27Q36523507-CF5A0190-3390-4244-8485-60F8DAB593C5Q36558882-0729FA75-2830-42B2-B5F4-04FDD4404DA3Q36570136-9A75892D-3392-48A3-B182-C88A5B4A27D1
P2860
Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Development of defective and p ...... m ideal for cell reprogramming
@ast
Development of defective and p ...... m ideal for cell reprogramming
@en
Development of defective and p ...... m ideal for cell reprogramming
@nl
type
label
Development of defective and p ...... m ideal for cell reprogramming
@ast
Development of defective and p ...... m ideal for cell reprogramming
@en
Development of defective and p ...... m ideal for cell reprogramming
@nl
prefLabel
Development of defective and p ...... m ideal for cell reprogramming
@ast
Development of defective and p ...... m ideal for cell reprogramming
@en
Development of defective and p ...... m ideal for cell reprogramming
@nl
P2093
P2860
P50
P356
P1476
Development of defective and p ...... m ideal for cell reprogramming
@en
P2093
Birei Furuta
Eriko Uchida
Hideyuki Sato
Hiroaki Segawa
Hiromitsu Nakauchi
Kaori Motomura
Ken Nishimura
Manami Ohtaka
Satoko Takayasu
Teruhide Yamaguchi
P2860
P304
P356
10.1074/JBC.M110.183780
P407
P577
2010-12-07T00:00:00Z